血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2021 UKHCDO共识：重症血友病A的免疫耐受诱导（更新版）

2021-08-17 英国血友病中心医师组织 Haemophilia.2021 Aug 17.

血友病A

2021年8月，英国血友病中心医师组织(UKHCDO)更新发布了重症血友病A的免疫耐受诱导共识。共识纳入了艾米珠单抗作为预防性止血的建议，以降低患者的出血率，促进低剂量和低频率FVIII CFC作为大

中文标题：

2021 UKHCDO共识：重症血友病A的免疫耐受诱导（更新版）

英文标题：

Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update

发布机构：

英国血友病中心医师组织

发布日期：

2021-08-17

简要介绍：

2021年8月，英国血友病中心医师组织(UKHCDO)更新发布了重症血友病A的免疫耐受诱导共识。共识纳入了艾米珠单抗作为预防性止血的建议，以降低患者的出血率，促进低剂量和低频率FVIII CFC作为大多数儿童患者的免疫诱导。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 UKHCDO共识：重症血友病A的免疫耐受诱导（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2feb51c00216a43b, title=2021 UKHCDO共识：重症血友病A的免疫耐受诱导（更新版）, enTitle=Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update, guiderFrom=Haemophilia.2021 Aug 17., authorId=0, author=, summary=2021年8月，英国血友病中心医师组织(UKHCDO)更新发布了重症血友病A的免疫耐受诱导共识。共识纳入了艾米珠单抗作为预防性止血的建议，以降低患者的出血率，促进低剂量和低频率FVIII CFC作为大, cover=https://img.medsci.cn/2021829/1630242010832_2020535.jpg, journalId=0, articlesId=null, associationId=1375, associationName=英国血友病中心医师组织, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 17 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年8月，英国血友病中心医师组织(UKHCDO)更新发布了重症血友病A的免疫耐受诱导共识。共识纳入了艾米珠单抗作为预防性止血的建议，以降低患者的出血率，促进低剂量和低频率FVIII CFC作为大多数儿童患者的免疫诱导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=34844, tagName=血友病A)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=34844, guiderKeyword=血友病A, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3681, appHits=32, showAppHits=0, pcHits=381, showPcHits=3649, likes=0, shares=1, comments=2, approvalStatus=1, publishedTime=Sun Aug 29 22:36:28 CST 2021, publishedTimeString=2021-08-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 21:00:18 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:16:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 UKHCDO共识：重症血友病A的免疫耐受诱导（更新版）.pdf)])
2021 UKHCDO共识：重症血友病A的免疫耐受诱导（更新版）.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071670, encodeId=d59a10e16700f, content=<a href='/topic/show?id=bcd6889e9d5' target=_blank style='color:#2F92EE;'>#血友病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88979, encryptionId=bcd6889e9d5, topicName=血友病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 09:57:20 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055635, encodeId=5652105563531, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:33:40 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-11-19 病毒猎手

    #血友病#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071670, encodeId=d59a10e16700f, content=<a href='/topic/show?id=bcd6889e9d5' target=_blank style='color:#2F92EE;'>#血友病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88979, encryptionId=bcd6889e9d5, topicName=血友病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Nov 19 09:57:20 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055635, encodeId=5652105563531, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:33:40 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 13f0c37dm61暂无昵称

    值得学习

    0

拓展阅读

血友病A诊疗指南（2022年v2）

中华人民共和国国家卫生健康委员会 · 2022-07-30

药物代谢动力学指导血友病A治疗的中国专家共识

中国血友病协作组 · 2022-10-30